TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Glycomic Therapeutics Market – By Class
1.3.2 South & Central America Glycomic Therapeutics Market – By Structures
1.3.3 South & Central America Glycomic Therapeutics Market – By Indications
1.3.4 South & Central America Glycomic Therapeutics Market – By Mode of Action
1.3.5 South & Central America Glycomic Therapeutics Market – By Country
2. South & Central America Glycomic Therapeutics Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Glycomic Therapeutics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America – PEST Analysis
4.3 Expert Opinion
5. South & Central America Glycomic Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Wide Application in Various Disorders Followed by the Development of New Treatment Processes
5.1.2 Increasing Research and Development In the Field of Glycomic Therapeutics
5.2 Market Restraints
5.2.1 Shortage of Skilled Professionals and Lack of Research & Development laboratories in Developing Countries.
5.3 Market Opportunities
5.3.1 Wide Applications of Glycomics in Therapeutics
5.4 Future Trends
5.4.1 New Tools in Glycomics Research
5.5 Impact Analysis
6. Glycomic Therapeutics Market– South & Central America Analysis
6.1 South & Central America Glycomic Therapeutics Market Revenue Forecast and Analysis
6.1.1 South & Central America: Glycomic Therapeutics Market Revenue and Forecasts to 2028, (US$ Million)
7. South & Central America Glycomic Therapeutics Market Revenue and Forecast to 2028– by Class
7.1 Overview
7.2 South & Central America Glycomic Therapeutics Market, By Class 2022 & 2028 (%)
7.2.1 South & Central America: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)
7.3 Isolated
7.3.1 Overview
7.3.2 South & Central America Isolated Revenue and Forecast to 2028 (US$ Million)
7.4 Synthetic
7.4.1 Overview
7.4.2 South & Central America Synthetic - Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Glycomics Therapeutics Market Analysis and Forecasts To 2028 – By Indication
8.1 Overview
8.2 South & Central America Glycomics Market, By Indication 2022 & 2028 (%)
8.2.1 South & Central America: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)
8.3 Thrombosis and Chemoprophylaxis
8.3.1 Overview
8.3.2 South & Central America Thrombosis and chemoprophylaxis Revenue and Forecast to 2028 (US$ Million)
8.4 Anaemia
8.4.1 Overview
8.4.2 South & Central America Anaemia Revenue and Forecast to 2028 (US$ Million)
8.5 Anti-adhesive and Anti-inflammatory
8.5.1 Overview
8.5.2 South & Central America Anti-adhesive and Anti-inflammatory Revenue and Forecast to 2028 (US$ Million)
8.6 Cataract
8.6.1 Overview
8.6.2 South & Central America Cataract Revenue and Forecast to 2028 (US$ Million)
8.7 Gaucher’s diseases
8.7.1 Overview
8.7.2 South & Central America Gaucher’s diseases Revenue and Forecast to 2028 (US$ Million)
8.8 MPS-1 & IV
8.8.1 Overview
8.8.2 South & Central America MPS-1 & IV Revenue and Forecast to 2028 (US$ Million)
8.9 Cancer
8.9.1 Overview
8.9.2 South & Central America Cancer Revenue and Forecast to 2028 (US$ Million)
8.10 Alzheimer's
8.10.1 Overview
8.10.2 South & Central America Alzheimer's Revenue and Forecast to 2028 (US$ Million)
8.11 Influenza Type A and B
8.11.1 Overview
8.11.2 South & Central America Influenza Type A and B Revenue and Forecast to 2028 (US$ Million)
8.12 Others
8.12.1 Overview
8.12.2 South & Central America Others Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Glycomic Therapeutics Market Revenue and Forecast to 2028 – by Structures
9.1 Overview
9.2 South & Central America Glycomic Therapeutics Market, By Structures 2022 & 2028 (%)
9.2.1 South & Central America: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)
9.2.1.1 South & Central America: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)
9.2.1.2 South & Central America: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)
9.2.1.3 South & Central America: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)
9.2.1.4 South & Central America: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)
9.3 Glycoproteins
9.3.1 Overview
9.3.2 South & Central America Glycoproteins - Market Revenue and Forecast to 2028 (US$ Million)
9.4 Targeting Sialic Acid
9.4.1 Overview
9.4.2 South & Central America Targeting Sialic Acid - Market Revenue and Forecast to 2028 (US$ Million)
9.4.3 Zanamivir
9.4.3.1 Overview
9.4.3.2 South & Central America Zanamivir - Market Revenue and Forecast to 2028 (US$ Million)
9.4.4 Oseltamivir
9.4.4.1 Overview
9.4.4.2 South & Central America Oseltamivir - Market Revenue and Forecast to 2028 (US$ Million)
9.5 Proteoglycans
9.5.1 Overview
9.5.2 South & Central America Proteoglycans - Market Revenue and Forecast to 2028 (US$ Million)
9.6 Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans
9.6.1 Overview
9.6.2 South & Central America Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans - Market Revenue and Forecast to 2028 (US$ Million)
9.7 Targeting Glycosaminoglycans
9.7.1 Overview
9.7.2 South & Central America Targeting Glycosaminoglycans - Market Revenue and Forecast to 2028 (US$ Million)
9.7.3 Heparin
9.7.3.1 Overview
9.7.3.2 South & Central America Heparin - Market Revenue and Forecast to 2028 (US$ Million)
9.7.4 Hyaluronan (HA)
9.7.4.1 Overview
9.7.4.2 South & Central America Hyaluronan (HA)- Market Revenue and Forecast to 2028 (US$ Million)
9.7.5 Laronidase
9.7.5.1 Overview
9.7.5.2 South & Central America Laronidase - Market Revenue and Forecast to 2028 (US$ Million)
9.7.6 Galsulfase (Naglazyme)
9.7.6.1 Overview
9.7.6.2 South & Central America Galsulfase (Naglazyme) - Market Revenue and Forecast to 2028 (US$ Million)
9.7.7 Hyaluronidase (Cumulase)
9.7.7.1 Overview
9.7.7.2 South & Central America Hyaluronidase (Cumulase) - Market Revenue and Forecast to 2028 (US$ Million)
9.7.8 Others
9.7.8.1 Overview
9.7.8.2 South & Central America Others - Market Revenue and Forecast to 2028 (US$ Million)
9.8 Targeting Glycosphingolipids
9.8.1 Overview
9.8.2 South & Central America Targeting Glycosphingolipids - Market Revenue and Forecast to 2028 (US$ Million)
9.8.3 Imiglucerase (Cerezyme)
9.8.3.1 Overview
9.8.3.2 South & Central America Imiglucerase (Cerezyme)- Market Revenue and Forecast to 2028 (US$ Million)
9.8.3.3 Agalsidase (Fabrazyme)
9.8.3.3.1 Overview
9.8.3.3.2 South & Central America Agalsidase (Fabrazyme) - Market Revenue and Forecast to 2028 (US$ Million)
9.8.3.4 N-butyl-deoxynojirimycin (DNJ)
9.8.3.4.1 Overview
9.8.3.4.2 South & Central America N-butyl-deoxynojirimycin (DNJ) - Market Revenue and Forecast to 2028 (US$ Million)
9.8.4 Others
9.8.4.1 Overview
9.8.4.2 South & Central America Others - Market Revenue and Forecast to 2028 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 South & Central America Others - Market Revenue and Forecast to 2028 (US$ Million)
9.9.3 Acarbose
9.9.3.1 Overview
9.9.3.2 South & Central America Acarbose - Market Revenue and Forecast to 2028 (US$ Million)
9.9.3.3 Alglucosidase Alfa (Myozyme)
9.9.3.3.1 Overview
9.9.3.3.2 South & Central America Alglucosidase Alfa (Myozyme) - Market Revenue and Forecast to 2028 (US$ Million)
9.9.3.4 Allosamidin
9.9.3.4.1 Overview
9.9.3.4.2 South & Central America Allosamidin - Market Revenue and Forecast to 2028 (US$ Million)
9.9.4 Others
9.9.4.1 Overview
9.9.4.2 South & Central America Others - Market Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Glycomic Therapeutics Market Revenue and Forecast to 2028 – by Mode of Action
10.1 Overview
10.2 South & Central America Glycomic Therapeutics Market, By Mode of Action 2022 & 2028 (%)
10.2.1 South & Central America: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)
10.3 Inhibits Neuraminidase
10.3.1 Overview
10.3.2 South & Central America Inhibits Neuraminidase - Market Revenue and Forecast to 2028 (US$ Million)
10.4 Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate
10.4.1 Overview
10.4.2 South & Central America Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate - Market Revenue and Forecast to 2028 (US$ Million)
10.5 Erythropoietin And Enzyme Replacement Therapy (ERT)
10.5.1 Overview
10.5.2 South & Central America Erythropoietin And Enzyme Replacement Therapy (ERT) - Market Revenue and Forecast to 2028 (US$ Million)
10.6 Tissue Plasminogen Activator
10.6.1 Overview
10.6.2 South & Central America Tissue Plasminogen Activator - Market Revenue And Forecasts To 2028 (US$ Million)
10.7 Inhibits Glucosylceramide Synthase
10.7.1 Overview
10.7.2 South & Central America Inhibits Glucosylceramide Synthase - Market Revenue And Forecasts To 2028 (US$ Million)
10.8 Interleukin 1 And 2 And 3
10.8.1 Overview
10.8.2 South & Central America Interleukin 1 And 2 And 3- Market Revenue And Forecasts To 2028 (US$ Million)
10.9 Beta And Gamma Interferons
10.9.1 Overview
10.9.2 South & Central America Beta And Gamma Interferons- Market Revenue And Forecasts To 2028 (US$ Million)
10.10 Others
10.10.1 Overview
10.10.2 South & Central America Others- Market Revenue And Forecasts To 2028 (US$ Million)
11. South & Central America Glycomic Therapeutics Market Revenue and Forecasts to 2028 – Country Analysis
11.1 South & Central America: Glycomic Therapeutics Market
11.1.1 Overview
11.1.2 South & Central America: Glycomic Therapeutics Market, by Country, 2021 & 2028 (%)
11.1.2.1 Brazil: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.1.1 Brazil: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.1.2 Brazil: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)
11.1.2.1.3 Brazil: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)
11.1.2.1.3.1 Brazil: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)
11.1.2.1.3.2 Brazil: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)
11.1.2.1.3.3 Brazil: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)
11.1.2.1.3.4 Brazil: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)
11.1.2.1.4 Brazil: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)
11.1.2.1.5 Brazil: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)
11.1.2.2 Argentina: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.2.1 Argentina: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.2.2 Argentina: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)
11.1.2.2.3 Argentina: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)
11.1.2.2.3.1 Argentina: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)
11.1.2.2.3.2 Argentina: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)
11.1.2.2.3.3 Argentina: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)
11.1.2.2.3.4 Argentina: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)
11.1.2.2.4 Argentina: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)
11.1.2.2.5 Argentina: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)
11.1.2.3 Rest of South and Central America: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.3.1 Rest of SCAM: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.3.2 Rest of SCAM: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)
11.1.2.3.3 Rest of SCAM: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)
11.1.2.3.3.1 Rest of SCAM: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)
11.1.2.3.3.2 Rest of SCAM: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)
11.1.2.3.3.3 Rest of SCAM: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)
11.1.2.3.3.4 Rest of SCAM: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)
11.1.2.3.4 Rest of SCAM: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)
11.1.2.3.5 Rest of SCAM: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)
12. South & Central America Glycomic Therapeutics Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Glycomic Therapeutics Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 BioMarin Pharmaceutical Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Genzyme Corporation (Sanofi)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bayer AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 GlaxoSmithKline plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms in Glycomic Therapeutics Market
LIST OF TABLES.
Table 1. South & Central America: Glycomic Therapeutics Market Revenue and Forecasts to 2028, (US$ Million)
Table 2. South & Central America Glycomic Therapeutics Market, by C lass – Revenue and Forecast to 2028 (US$ Million)
Table 3. South & Central America Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 4. South & Central America Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (USD Million)
Table 5. South & Central America Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (USD Million)
Table 6. South & Central America Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (USD Million)
Table 7. South & Central America Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (USD Million)
Table 8. South & Central America Glycomic Therapeutics Market, by Others– Revenue and Forecast to 2028 (USD Million)
Table 9. South & Central America Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (USD Million)
Table 10. Brazil Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (US$ Million)
Table 11. Brazil Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (US$ Million)
Table 12. Brazil Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (US$ Million)
Table 13. Brazil Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (US$ Million)
Table 14. Brazil Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (US$ Million)
Table 15. Brazil Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (US$ Million)
Table 16. Brazil Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 17. Brazil Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (US$ Million)
Table 18. Argentina Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (US$ Million)
Table 19. Argentina Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (US$ Million)
Table 20. Argentina Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (US$ Million)
Table 21. Argentina Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (US$ Million)
Table 22. Argentina Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (US$ Million)
Table 23. Argentina Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (US$ Million)
Table 24. Argentina Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 25. Argentina Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of SCAM Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of SCAM Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of SCAM Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (US$ Million)
Table 29. Rest of SCAM Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (US$ Million)
Table 30. Rest of SCAM Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of SCAM Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of SCAM Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of SCAM Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (US$ Million)
Table 34. Organic Developments in the Glycomic Therapeutics Market
Table 35. Inorganic Developments in the Glycomic Therapeutics Market
Table 36. Glossary of Terms in Glycomic Therapeutics Market